IP Library Granted Patent US 8,168,599
Granted Patent B2
US 8,168,599 · App. 12/659,656 · Granted May 1, 2012

Composition and method for healing tissues

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,168,599
App. No.
12/659,656
Granted
May 1, 2012
Kind
B2
Abstract

The composition and method for healing tissues is a medicinal composition for facilitating the growth, protection and healing of tissues and cells in animals and humans. The composition is formulated as a either a powder, gel, paste, film, fluid injectable, rehydratable freeze-dried paste or sponge, sprayable solution, topically applied patch with adhesive and reservoir system, an intermediate for coatables such as films and bandages, a matrix for membranes, or as a matrix of flexible polymer(s), or delivered as either an orally ingestible liquid, tablet or capsule. The main ingredient of the formulated compositions is hydrolyzed collagen, which can be combined with polysulfated glycosaminoglycans, hyaluronic acid or salts thereof, or a glucosamine salt, and mixtures thereof. The composition may be formulated as an aqueous eye drop solution.

Claims (7)

1. A method for achieving an effect in a patient comprising administering a therapeutically effective amount of a medicinal composition to the patient, wherein the effect is for treating eye tissue and ulcers, for removing redness of the eye, for providing lubrication for the eye, for providing moisture for eye dryness, for relieving eye pain, for promoting tissue and cell growth, for protecting cells and tissues, for reducing scar tissue and repairing damaged animal tissues, or for topical wound care, wherein the composition comprises hydrolyzed Type I collagen having an average molecular weight ranging from 1,000 to 10,000 Daltons and 0.01-15% wt. of the medicinal composition, at least one therapeutic agent selected from the group consisting of hyaluronic acid and salts thereof, a polysulfated glycosaminoglycan, carboxymethylcellulose, and tetrahydrozoline hydrochloride, the hydrolyzed collagen serving as a pharmaceutical carrier for said at least one therapeutic agent.

2. The method according to claim 1 , wherein said composition further comprises a hypertonicity agent selected from the group consisting of sodium chloride and boric acid, the hydrolyzed collagen serving as a pharmaceutical carrier for said at least one hypertonicity agent.

3. The method according to claim 2 , wherein said composition further further includes a preservative.

4. The method according to claim 3 , wherein said preservative comprises benzalkonium chloride.

5. The method according to claim 3 , wherein said preservative comprises edetate disodium.

6. The method according to claim 1 , wherein said composition comprises a form selected from the group consisting of a powder, a gel, a foam, a paste, and a film.

7. The method according to claim 1 , wherein said composition comprises an aqueous solution and a pH between 7.1 and 7.3.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 24, 2025
From: THE HYMED GROUP CORPORATION; APPLIED NUTRITIONALS, LLC; PETITO, GEORGE D.
To: SANARA MEDTECH APPLIED TECHNOLOGIES, LLC
Reel/Frame 070604/0811 →
RELEASE OF SECURITY INTEREST Recorded Apr 18, 2024
From: CADENCE BANK
To: SANARA MEDTECH APPLIED TECHNOLOGIES, LLC
Reel/Frame 067153/0205 →
SECURITY INTEREST Recorded Aug 1, 2023
From: SANARA MEDTECH APPLIED TECHNOLOGIES, LLC
To: CADENCE BANK
Reel/Frame 064453/0210 →
Continuity (6)
Continuation 11071464 · Mar 4, 2005
Continuation In Part 10457599 · Jun 10, 2003
Continuation 09983274 · Oct 23, 2001
Continuation In Part 09360169 · Jul 26, 1999
Continuation In Part 09046710 · Mar 24, 1998
Related Publication 20100173868A1 · Jul 8, 2010